ISOPTO CARPINE Drug Patent Profile
✉ Email this page to a colleague
When do Isopto Carpine patents expire, and when can generic versions of Isopto Carpine launch?
Isopto Carpine is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ISOPTO CARPINE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isopto Carpine
A generic version of ISOPTO CARPINE was approved as pilocarpine hydrochloride by PADAGIS US on November 16th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOPTO CARPINE?
- What are the global sales for ISOPTO CARPINE?
- What is Average Wholesale Price for ISOPTO CARPINE?
Summary for ISOPTO CARPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Patent Applications: | 3,807 |
| What excipients (inactive ingredients) are in ISOPTO CARPINE? | ISOPTO CARPINE excipients list |
| DailyMed Link: | ISOPTO CARPINE at DailyMed |
US Patents and Regulatory Information for ISOPTO CARPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ISOPTO CARPINE | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 200890-001 | Jun 22, 2010 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | ISOPTO CARPINE | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 200890-002 | Jun 22, 2010 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | ISOPTO CARPINE | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 200890-003 | Jun 22, 2010 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
